Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v7-FR
Language English French
Date Updated 2017-07-06 2017-06-06
Drug Identification Number 02225166 02225166
Brand name SUPREFACT SUPREFACT
Common or Proper name Suprefact Inj. M.D. 1mg/ml - vials Suprefact Inj. M.D. 1mg/ml - vials
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH CHEPLAPHARM ARZNEIMITTEL GMBH
Ingredients BUSERELIN BUSERELIN
Strength(s) 1MG 1MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 2 X 5.5ml 2 X 5.5ml
ATC code L02AE L02AE
ATC description HORMONES AND RELATED AGENTS HORMONES AND RELATED AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2017-05-15 2017-05-15
Estimated end date 2017-06-09 2017-06-09
Actual end date 2017-06-05 2017-06-05
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Manufacturing Delay Manufacturing Delay
Health Canada comments